Axitinib Clinical Trials
17 recruitingDrug
Phase 215Phase 12Phase 31
Showing 1–17 of 17 trials
Recruiting
Phase 2
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more
NRG Oncology240 enrolled318 locationsNCT05327686
Recruiting
Phase 2
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Renal Cell CarcinomaKidney CancerRenal Cancer+1 more
University of Colorado, Denver17 enrolled3 locationsNCT05969496
Recruiting
Phase 2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Advanced Solid TumorsMultiple MyelomaLymphoma, Non-Hodgkin
Canadian Cancer Trials Group720 enrolled10 locationsNCT03297606
Recruiting
Phase 2
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Metastatic Renal Cell CarcinomaRenal Cell CarcinomaKidney Cancer+3 more
Stephanie Berg25 enrolled2 locationsNCT07123090
Recruiting
Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmAdvanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center111 enrolled1 locationNCT04693468
Recruiting
Phase 2
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
NeoplasmsClear Cell Renal Cell CarcinomaMalignant Neoplasms+1 more
Yonsei University78 enrolled1 locationNCT07469683
Recruiting
Phase 2
Axitinib + Ipilimumab in Advanced Melanoma
Melanoma
H. Lee Moffitt Cancer Center and Research Institute25 enrolled1 locationNCT04996823
Recruiting
Phase 2
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Renal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.260 enrolled1 locationNCT06962787
Recruiting
Phase 2
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
CancerNeoplasmsNeoplasia+1 more
Ulrik Lassen300 enrolled7 locationsNCT04341181
Recruiting
Phase 1Phase 2
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Renal Cell CarcinomaFirst-line Treatment
Hao Zeng33 enrolled1 locationNCT05808608
Recruiting
Phase 3
CARE1 Pragmatic Clinical Trial
Metastatic Kidney CancerMetastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris1,250 enrolled46 locationsNCT06364631
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
Collecting Duct Carcinoma
Peking University Cancer Hospital & Institute30 enrolled2 locationsNCT06211114
Recruiting
Phase 2
Combination of Toripalimab and JS004 Therapy for ccRCC
Clear Cell Renal Cell Carcinoma
Fudan University80 enrolled1 locationNCT06690697
Recruiting
Phase 2
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd54 enrolled6 locationsNCT05420220
Recruiting
Phase 2
The Drug Rediscovery Protocol (DRUP Trial)
CancerNeoplasmNeoplasia+1 more
The Netherlands Cancer Institute1,550 enrolled36 locationsNCT02925234
Recruiting
Phase 2
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
Metastatic Renal Cell Carcinoma
Consorzio Oncotech118 enrolled23 locationsNCT05817903
Recruiting
Phase 2
Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
Non-clear Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School30 enrolled2 locationsNCT05768464